Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dextroamphetamine sulfate
Drug ID BADD_D00637
Description Dextroamphetamine is the dextrorotary enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Indications and Usage Used to treat attention deficit hyperactivity disorder (ADHD).
Marketing Status Prescription; Discontinued
ATC Code N06BA02
DrugBank ID DB01576
KEGG ID D02078
MeSH ID D003913
PubChem ID 5825
TTD Drug ID D0T3LF
NDC Product Code 24338-855; 0406-8958; 63629-2374; 24338-856; 75826-125; 0115-9927; 11534-188; 24338-852; 64896-674; 13107-036; 13107-035; 0406-8961; 45963-304; 43386-870; 43386-871; 51862-346; 0555-0952; 24338-853; 10702-065; 75826-121; 75826-120; 52536-510; 0115-9928; 52536-500; 24338-850; 51634-0222; 0115-9929; 11014-0322; 68382-944; 75826-126; 61960-0210; 51862-345; 11014-0323; 45963-303; 0406-8960; 51862-344; 0555-0953; 0406-8962; 52536-520; 64896-675; 68382-941; 0406-8959; 52536-530; 68382-942; 75826-124; 24338-851; 68382-943; 11534-189; 68382-945; 11014-0324; 45963-305; 10702-066; 66993-359; 49812-0058; 24338-854; 63629-2375; 21724-701; 75826-123; 75826-122; 0406-1950; 64896-673; 52536-515; 65392-0114
Synonyms Dextroamphetamine | Dexamphetamine | Dexamfetamine | dextro-Amphetamine | dextro Amphetamine | d-Amphetamine | d Amphetamine | Dexedrine | DextroStat | Oxydess | Curban | Dextroamphetamine Sulfate | Sulfate, Dextroamphetamine | Dextro-Amphetamine Sulfate | Dextro Amphetamine Sulfate | d-Amphetamine Sulfate | d Amphetamine Sulfate
Chemical Information
Molecular Formula C18H28N2O4S
CAS Registry Number 51-63-8
SMILES CC(CC1=CC=CC=C1)N.CC(CC1=CC=CC=C1)N.OS(=O)(=O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Acidosis14.01.03.002--
Aggression19.05.01.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Alopecia23.02.02.001--
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angina pectoris24.04.04.002; 02.02.02.002--
Angioedema23.04.01.001; 10.01.05.009--Not Available
Anhedonia19.15.02.007--Not Available
Anxiety19.06.02.002--
Arrhythmia02.03.02.001--Not Available
Asthenia08.01.01.001--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Blood pressure increased13.14.03.005--Not Available
Body temperature increased13.15.01.001--Not Available
Cardiomyopathy02.04.01.001--Not Available
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
Chills15.05.03.016; 08.01.09.001--
Choreoathetosis17.01.01.003--Not Available
Colitis ischaemic24.04.08.012; 07.08.01.004--Not Available
Coma17.02.09.001--Not Available
Compulsions19.06.05.003--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Delirium19.13.02.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Disturbance in attention19.21.02.002; 17.03.03.001--
Dizziness17.02.05.003; 02.01.02.004; 24.06.02.007--
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages